Medical Condition News

RSS
Occasional drinking and physically activity linked with reduced risk of developing visual impairment

Occasional drinking and physically activity linked with reduced risk of developing visual impairment

Ipsen: Dysport Phase IIa clinical trial effective in treatment of NDO

Ipsen: Dysport Phase IIa clinical trial effective in treatment of NDO

Researchers use "big data" analytics to predict triple-negative breast cancer and other cancers with 95% accuracy

Researchers use "big data" analytics to predict triple-negative breast cancer and other cancers with 95% accuracy

Study: Daily dietary supplements not associated with reduced risk for CVD in elderly

Study: Daily dietary supplements not associated with reduced risk for CVD in elderly

Study provides evidence that sepsis-related mortality has steadily decreased over time

Study provides evidence that sepsis-related mortality has steadily decreased over time

Restless legs syndrome alters expression of critical gene during fetal development of brain

Restless legs syndrome alters expression of critical gene during fetal development of brain

RaySearch signs distribution agreement with AlphaXRT for RayStation

RaySearch signs distribution agreement with AlphaXRT for RayStation

PredictND project aims at validating new procedures for early diagnosis of memory disorders

PredictND project aims at validating new procedures for early diagnosis of memory disorders

Added benefit of ipilimumab in advanced melanoma not proven for non-pretreated patients

Added benefit of ipilimumab in advanced melanoma not proven for non-pretreated patients

Elevated body temperature linked to fatigue in relapsing-remitting multiple sclerosis

Elevated body temperature linked to fatigue in relapsing-remitting multiple sclerosis

Shiseido discovers new function of skin immunity that sedates stimuli response of Langerhans cells

Shiseido discovers new function of skin immunity that sedates stimuli response of Langerhans cells

Playing science-based mobile gaming app for 25 minutes can reduce anxiety

Playing science-based mobile gaming app for 25 minutes can reduce anxiety

Sea lions exposed to toxin in algae develop form of epilepsy that is similar to humans

Sea lions exposed to toxin in algae develop form of epilepsy that is similar to humans

Study suggests that screening children for retinoblastoma may not improve outcomes for majority of patients

Study suggests that screening children for retinoblastoma may not improve outcomes for majority of patients

Shortness of breath while bending over is a new heart failure symptom

Shortness of breath while bending over is a new heart failure symptom

Anaphylaxis Campaign, Boots UK partner to support patients with severe allergy

Anaphylaxis Campaign, Boots UK partner to support patients with severe allergy

St. Jude Medical announces first enrollments in LEADLESS Pacemaker Observational Study

St. Jude Medical announces first enrollments in LEADLESS Pacemaker Observational Study

Lung cancer cells use novel mechanism to block detection by natural killer cell

Lung cancer cells use novel mechanism to block detection by natural killer cell

Amgen announces results from Phase 3 TESLA Trial of evolocumab in patients with HoFH

Amgen announces results from Phase 3 TESLA Trial of evolocumab in patients with HoFH

Primary ADT proves ineffective in early stage prostate cancer patients

Primary ADT proves ineffective in early stage prostate cancer patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.